Since BoltzDesign1 just got published, people might also be interested in github.com/escalante-bio/… by Nick Boyd It has a nicely flexible system for including custom losses. It's also surprisingly little code on top of Boltz (and the Jaxified Joltz).

Announcing Axiom: Eliminating drug toxicity, without using animals! Alex Beatson and I founded Axiom a little over over a year ago with the mission of eliminating drug toxicity by replacing traditional experiments, such as animal testing, with AI models. We are excited to

an idea whose time has more than come: in silico toxicity testing. Better, more accurate, more humane, and faster. LFG: Brandon White & axi.om

My sense is we need new architectures because most bio datasets are too small/noisy for vanilla transformers so we bake in inductive biases (i.e. triangle attention in AF2). I'd love to see efficient graph architectures for small molecules or going beyond LLMs for modeling DNA

We’re excited to introduce Chai-2, a major breakthrough in molecular design. Chai-2 enables zero-shot antibody discovery in a 24-well plate, exceeding previous SOTA by >100x. Thread👇

Excited to announce our new product: AI Protein Design Copilot Tamarind Bio has been the leading provider to use the top AI tools in computational protein engineering. Today we announce a completely new way to interface with computational molecular design. Available now!

How Genentech/Prescient Design use AI to design 3-100x better antibodies Genentech uses lab in a loop as an iterative approach for designing antibodies by marrying generative machine learning models, property predictors and data from in vitro experimentation. Thread👇 The

🤝Excited to partner with Tamarind Deniz Kavi to build towards an agentic AI protein designer. 🔁 Agentic protein optimization — Starting from a sequence, Biomni iteratively improves thermostability by orchestrating AlphaFold-2, ThermoMPNN, and reasoning over predictions and

great to see Dimension backed axi.om and Dimension cofounded achira.ai both on Mario Gabriele 🦊's The Future 50 list below!!

Excited to introduce our newest team member, Sriram (“Rami”) Hathwar! 🚀 From winning the US Scripps National Spelling Bee, to enrolling in a Chemistry/Bio/CS curriculum at Princeton, to developing bioinformatics tools at a clinical stage biotech, Rami embodies the

a few months ago we DIMENSION quietly funded a team of 3 MIT computer scientists & mathematicians at the forefront of ML & physics+simulation for enzyme design. these. guys. are. cracked today they're stealthily building the early team. if you're world class, look below 👇

Deep Tech Software Engineer: voltaris.notion.site/software-engin…

We've raised $8.6m to build leading AI tools for the biopharma industry! Our seed financing was led by Kleiner Perkins and DIMENSION , with participation from ACME Capital, Comma Capital, Liquid 2 Ventures, Not Boring, Audacious Ventures, Lux Capital, and leaders in AI and biotechnology

Congrats on the launch of most recent DIMENSION co Convoke! Alex Telford okaymaged and Vikas Velagapudi are an incredible team building an AI operating system for life science. From data ingestion, to clinical insights, to program tracking, Convoke allows customers to

Excited to announce DIMENSION's partnership with Gary D. Glick and the entire Odyssey Therapeutics team on an oversubscribed Series D. They are moving ahead to an exciting chapter where the company will translate multiple programs out of a massively productive discovery platform.